• SENSEX
    NIFTY 50
Home Market Stocks
Market

Aurobindo Pharma surges over 18% on receiving EIR from USFDA

Updated : February 19, 2020 11:46 AM IST

At 11:42 am, Aurobindo Pharma was trading 18.57 percent higher at Rs 593.10 per share.
Aurobindo Pharma surges over 18% on receiving EIR from USFDA

Subscribe to Moneycontrol Pro at ₹499 for the first year and get access to exclusive offers. Use Code: PRO2021. Limited period offer. *T&C apply

You May Also Like

Home First Finance Company IPO fully subscribed on day 1

Home First Finance Company IPO fully subscribed on day 1

Bajaj Auto Q3 profit rises 23% YoY to Rs 1,556.3 cr; reports highest ever turnover

Bajaj Auto Q3 profit rises 23% YoY to Rs 1,556.3 cr; reports highest ever turnover

Expect Brent crude to be around $51-52 per barrel in 1st half of 2021, says Wood Mackenzie’s Sushant Gupta

Expect Brent crude to be around $51-52 per barrel in 1st half of 2021, says Wood Mackenzie’s Sushant Gupta

Trending on CNBC-TV18

Live TV

recommended for you

Advertisement